Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

BrainsWay (BWAY) commented on the recent news issued by Evernorth Behavioral Health, a division of the Cigna Group (CI), which serves over 18 million covered lives across 12 states, that it will no longer require prior authorization for transcranial magnetic stimulation, TMS, for contracted providers whose patients have coverage under Evernorth and Cigna Healthcare plans. The Evernorth press release stated that the change will be effective on March 6, 2026. “Evernorth’s decision to eliminate the requirement for contracted providers to have patients obtain prior authorizations for TMS treatment marks an important step forward in expanding patient access to this effective and well-accepted therapy. This change empowers providers to deliver timely care to patients who meet Evernorth’s TMS policy selection criteria,” stated Hadar Levy, CEO at BrainsWay.